- Price
- $37.81
- Day
- -0.99%
- Mkt Cap
- $18.19B
- 52W Range
- $36.59 – $66.14
- Volume
- 3.80M
- Beta
- 0.75
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Rollins (ROL) To Contact Him Directly To Discuss Their Options
Read full article
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rollins, Inc. (“Rollins” or the “Company”) (NYSE: ROL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read full article
LOS ANGELES--(BUSINESS WIRE)---- $ROL--ROL Investors Have Opportunity to Join Rollins, Inc. Fraud Investigation with SBS Law.
Read full article
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
Read full article
Multinational pest control and hygiene company Rentokil Initial plc reported its H1 2026 results on Thursday, which led to a 20% drop in share price. In this update, I'll review Rentokil's performance so far this year, looking for the reasons behind the underperformance, and give an update on the progress of the (still ongoing) turnaround. I'll explain why the withdrawn North America margin guidance matters more than the reported organic growth figures.
Read full article
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
Read full article
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Rollins, Inc. (“Rollins” or the “Company”) (NYSE: ROL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
Read full article
NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rollins, Inc. ("Rollins" or the "Company") (NYSE: ROL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read full article
Investors need to pay close attention to ROL stock based on the movements in the options market lately.
Read full article
Rollins' 38% six-month slide improved its entry price, but earnings misses, margin pressure and a premium valuation still argue for caution.
Read full article
ROL is navigating softer residential demand as commercial, termite, technology and acquisitions support growth.
Read full article
Bank of Nova Scotia raised its position in shares of Rollins, Inc. (NYSE: ROL) by 100.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 105,197 shares of the business services provider's stock after purchasing an additional 52,815 shares during the period.
Read full article